DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kim H-S, Kang J, Hwang D. et al; HOST-REDUCE-POLYTECH-ACS investigators.
Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial.
Lancet 2020;
396 (10257): 1079-1089
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.